Generic drug company Mylan NV on Wednesday offered to acquire over-the-counter giant Perrigo Co for US$28.9 billion in the latest proposed megamerger in the pharmaceutical sector.
Shares of both companies soared after Mylan announced the US$205 per share, cash and stock bid for Perrigo, the maker of such popular nonprescription products as Sudafed, Claritin and NyQuil. The offer represented a premium of 25 percent over Perrigo’s closing price on Thursday last week of US$163.73 in New York trading. US markets were closed on Friday.
The deal would combine companies with annual sales of more than US$15 billion and complementary businesses in specialty health brands, generics, over-the-counter and nutritional products.
“Our proposal is the natural culmination of our prior discussions and reflects our shared vision for the industry,” Mylan executive chairman Robert Coury said in a letter on Monday to Perrigo chief executive Joseph Papa.
“This is the right time for our two companies to move forward together, and Mylan and our board are firmly committed to making this combination a reality,” Coury wrote.
Perrigo said its board would meet to discuss the proposal and that “a further announcement will be made when appropriate.”
The deal comes on the heels of a series of large acquisitions in the global pharmaceutical industry, including transactions involving both Perrigo and Mylan, both of which shifted headquarters from the US to overseas to take advantage of lower tax rates.
Perrigo relocated to Dublin in 2013 following its acquisition of Irish pharmaceutical company Elan Corp for about US$8.6 billion.
The Elan transaction added the multiple sclerosis therapy Tysabri to its massive consumer business.
Mylan, long known as a leader in generics, shifted its headquarters to Amsterdam this year following a deal to buy Abbott Laboratories Inc’s non-US specialty and branded generic drug business for US$5.3 billion.
Mylan’s assets include a specialty business focused on respiratory and allergy therapies.
The company’s executives are now based in Potters Bar, England.
Softbank Group Corp plans to keep a stake in the chip designer Arm Ltd, even if it sells a partial interest to Nvidia Corp, the Nikkei reported. The companies are negotiating terms, the newspaper reported, citing sources. Softbank might take a stake in Nvidia after it buys Arm, the report said. Nvidia and Arm might also merge through a share swap, and Softbank would become a major shareholder in the combined company, it said. The two parties aim to reach a deal in the next few weeks, the sources said, asking not to be identified because the information is private. Nvidia is the
‘ONE-STOCK SHOW’: Turnover hit an all-time high as TSMC continued to determine the local market’s direction and surpassed Visa in market capitalization The TAIEX early yesterday hit an all-time intraday high on the back of soaring Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) shares, before tumbling back to the previous day’s close as the contract chipmaker could not single-handedly prop up the index. The TAIEX rose more than 400 points in the first 20 minutes of trading to hit a record 13,031.7 points, but later pared its gains to close down 0.01 percent at 12,586.73. Turnover was NT$343.252 billion (US$11.63 billion), the highest in the Taiwan Stock Exchange’s history. TSMC continued to dictate the market’s direction, as its early surge by the daily
MOVING FROM CHINA? The article did not name the company, but Foxconn, Wistron and Pegatron were among firms chosen for a production-linked incentive plan in India An Apple Inc vendor is looking at shifting six production lines to India from China, which could result in US$5 billion of iPhone exports from the South Asian nation, the Times of India reported, citing people familiar with the matter who it did not identify. The establishment of the facility would create about 55,000 jobs over about a year, the newspaper reported, not naming the Apple vendor. It would also cater to the domestic market and expand operations to include tablets and laptops, the newspaper reported. Samsung Electronics Co and Apple’s assembly partners are among 22 companies that have pledged 110 billion
Gold surged to a fresh record on Friday, fueled by US dollar weakness and low interest rates, while silver headed for its best month since 1979. Spot bullion is up more than 10 percent this month, as US real yields lingered near record lows. While the ferocity of rallies in gold and silver cooled in the middle of the week, most market watchers predict there might be more gains ahead. Both metals have added about 30 percent this year, with gold and silver exchange-traded funds boosting holdings to a record, as concern about the fallout from the COVID-19 pandemic fuels demand for